Mycophenolate Mofetil
29 interactions 1 explained in plain EnglishRead the full Mycophenolate Mofetil drug information page
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Mycophenolate Mofetil Omeprazole Gastrobim Explained Reduced mycophenolic acid exposure Details Mycophenolate Mofetil Acyclovir Avaclyr Increased acyclovir exposure and an increased risk of acyclovir-related adverse reactions Details Mycophenolate Mofetil Acyclovir Injection Avaclyr Increased acyclovir exposure and an increased risk of acyclovir-related adverse reactions Details Mycophenolate Mofetil Acyclovir Ophthalmic Avaclyr Increased acyclovir exposure and an increased risk of acyclovir-related adverse reactions Details Mycophenolate Mofetil Acyclovir Topical Zovirax Increased acyclovir exposure and an increased risk of acyclovir-related adverse reactions Details Mycophenolate Mofetil Amoxicillin Amoxi Drop Decreased mycophenolic acid plasma exposure Details Mycophenolate Mofetil Cholestyramine Resin Locholest® Reduced exposure of mycophenolic acid (MPA) and reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Colesevelam Welchol Reduced exposure of mycophenolic acid (MPA) and reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Colestipol Colestid Reduced exposure of mycophenolic acid (MPA) and reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Cyclosporine Injection Atopica Reduced mycophenolic acid (MPA) exposure and reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Cyclosporine Ophthalmic Cequa Reduced mycophenolic acid (MPA) exposure and reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Dexlansoprazole Dexilant Reduced mycophenolic acid exposure Details Mycophenolate Mofetil Esomeprazole Nexium Reduced mycophenolic acid exposure Details Mycophenolate Mofetil Esomeprazole Injection Nexium Reduced mycophenolic acid exposure Details Mycophenolate Mofetil Estradiol Delestrogen Reduced levonorgestrel exposure and reduced efficacy of combination oral contraceptive Details Mycophenolate Mofetil Estradiol Topical Divigel Reduced levonorgestrel exposure and reduced efficacy of combination oral contraceptive Details Mycophenolate Mofetil Estradiol Transdermal Patch Alora® Reduced levonorgestrel exposure and reduced efficacy of combination oral contraceptive Details Mycophenolate Mofetil Ganciclovir Cytovene® Oral Increased ganciclovir exposure and an increased risk of ganciclovir-related adverse reactions Details Mycophenolate Mofetil Ganciclovir Injection Cytovene® I.V.® Increased ganciclovir exposure and an increased risk of ganciclovir-related adverse reactions Details Mycophenolate Mofetil Ganciclovir Ophthalmic Zirgan Increased ganciclovir exposure and an increased risk of ganciclovir-related adverse reactions Details Mycophenolate Mofetil Lansoprazole Prevacid Reduced mycophenolic acid exposure Details Mycophenolate Mofetil Lanthanum Fosrenol® Reduced mycophenolic acid (MPA) exposure and possible reduced efficacy of mycophenolate mofetil Details Mycophenolate Mofetil Levonorgestrel After banger Reduced levonorgestrel exposure and reduced efficacy of combination oral contraceptive Details Mycophenolate Mofetil Levonorgestrel Intrauterine System Kyleena Reduced levonorgestrel exposure and reduced efficacy of combination oral contraceptive Details Mycophenolate Mofetil Metronidazole Flagyl Decreased mycophenolate plasma exposure and possible reduced efficacy Details Mycophenolate Mofetil Metronidazole Injection Flagyl Decreased mycophenolate plasma exposure and possible reduced efficacy Details Mycophenolate Mofetil Metronidazole Topical MetroCream® Decreased mycophenolate plasma exposure and possible reduced efficacy Details Mycophenolate Mofetil Metronidazole Vaginal MetroGel® Vaginal Decreased mycophenolate plasma exposure and possible reduced efficacy DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist